Pfizer shares plummet along with demand for Covid drugs

US pharmaceutical

The company’s stock has suffered its biggest monthly decline since 2020 as demand wanes for coronavirus products.

US pharmaceutical giant Pfizer released a disappointing earnings report on Tuesday, with a weaker-than-estimated sales outlook for its Covid-19 drugs.

Continue reading